The GPLGVRG peptide was designed to enhance PTX liposome accumulation in tumor microenvironments by leveraging MMP-2-mediated peptide degradation, which triggered the detachment of long-chain PEG moieties and facilitated tumor cell internalization of PTX. The gene discussed is MMP2; the disease is neoplasm.